Apotex and Sandoz have introduced generic versions of Celgene’s Revlimid (lenalidomide) in Canada, confirming their launches into a generic market for the multiple myeloma treatment that formed at the start of September and which also includes Dr Reddy’s and Natco.
Confirmed that it was “one of the first companies to offer a generic version of Revlimid on the Canadian market,” Sandoz said its version of lenalidomide was being offered in blister packs of 21 or 28 capsules